Visanji, Naomi P <br/><br/>
Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease.  [electronic resource] 

 -  Neurobiology of disease  Aug 2009 
 - 184-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1095-953X 
<br/><br/><label>Standard No.: </label>10.1016/j.nbd.2008.11.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine<br/>Animals<br/>Antiparkinson Agents--adverse effects<br/>Benzopyrans--pharmacology<br/>Callithrix<br/>Corpus Striatum--drug effects<br/>Disease Models, Animal<br/>Dopamine Antagonists--pharmacology<br/>Dopamine and cAMP-Regulated Phosphoprotein 32--metabolism<br/>Dyskinesia, Drug-Induced--etiology<br/>Enkephalins--metabolism<br/>Female<br/>Levodopa--adverse effects<br/>Male<br/>Oxidopamine<br/>Parkinsonian Disorders--chemically induced<br/>Protein Precursors--metabolism<br/>Pyrroles--pharmacology<br/>RNA, Messenger--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Dopamine D1--metabolism<br/>Receptors, Dopamine D2--metabolism<br/>Receptors, Dopamine D3--antagonists & inhibitors